While the iShares Nasdaq Biotechnology (IBB) fell nearly 4% today, biotech companies Dynavax Technologies Corporation (NASDAQ:DVAX) and Uniqure NV (NASDAQ:QURE) climbed sharply higher after presenting …
Chipotle Mexican Grill, Inc. (NYSE:CMG) is falling close to 5% after the company disclosed in a SEC filing that it received a subpoena …
Uniqure NV (NASDAQ: QURE), a leader in human gene therapy, announced preliminary topline results from the low-dose cohort of an ongoing Phase I/II clinical …
Uniqure NV (NASDAQ:QURE), a leader in human gene therapy, today announced the appointment of Dan Soland as the new Chief Executive Officer of the …
This week, analysts expressed bullish sentiments on both Uniqure NV (NASDAQ:QURE) and Can Fite Biopharma Ltd (ADR) (NYSEMKT:CANF) in light of new drug …
Analysts from Piper Jaffray and Cowen weigh in on the Netherlands-based biotechnology company Uniqure NV (NASDAQ:QURE) and technology company Supercom Ltd (NASDAQ:SPCB), as quarterly reports sent shares of both …
Uniqure NV (NASDAQ:QURE), a leader in human gene therapy, today announced financial results for the third quarter and nine months ending September 30, 2015, …
Here’s what to watch for this week from GW Pharmaceuticals PLC- ADR (NASDAQ:GWPH), Avago Technologies Ltd (NASDAQ:AVGO), Ambarella Inc (NASDAQ:AMBA), and Uniqure NV …
Uniqure NV (NASDAQ:QURE)’s presentation of 1-year follow-up data from patients with Sanfilippo B (MPS IIIB) and treated with the gene therapy AMT-110 is …
In a research note issued today, Chardan analyst Gbola Amusa maintained a Buy rating on shares of Uniqure NV (NASDAQ:QURE), and reduced the price target to …
